Drift in Susceptibility of Neisseria gonorrhoeae to Ciprofloxacin and Emergence of Therapeutic Failure

Ciprofloxacin, 500 mg, was introduced as the first-line therapy for gonorrhea at St. Mary’s Hospital, London, in 1989, when a surveillance program was initiated to detect the emergence of resistance. Isolates of Neisseria gonorrhoeae from consecutive patients attending the Jefferiss Wing, Genitourin...

Full description

Saved in:
Bibliographic Details
Main Authors: Ison, Catherine A., Woodford, Patricia J., Madders, Helen, Claydon, Elizabeth
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 1998
Subjects:
Mechanisms of Resistance
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC105966/
https://ncbi.nlm.nih.gov/pubmed/9797226
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items